Fig. 2.
Schematic representation of the molecular docking models of prostaglandin E2 (PGE2) receptor EP4 subtype (EP4) binding with FA (A), PGE2 (control, an agonist of EP4) (B), and grapiprant (control, an inhibitor of EP4) (C), respectively.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.